Paytm sells PayPay stake to SoftBank for $279.2 million

Date:

Share post:


Paytm has agreed to sell its stake in Japanese payments firm PayPay to SoftBank for $279.2 million, as the Indian firm sheds non-core assets following a bruising regulatory clampdown earlier this year.

The sale of Paytm’s stake in PayPay, which it received through acquisition rights six years ago, follows months of restructuring at the Indian firm that saw the company sell its entertainment ticketing unit to Zomato for $246 million in August.

PayPay, controlled by SoftBank and Yahoo Japan parent Z Holdings, is a leading payments app in Japan.

The stake sale will boost Paytm’s cash reserves to $1.46 billion as it attempts to recover market share in India’s fiercely competitive payments market. The company’s banking affiliate was severely restricted by regulators in January, leading to an exodus of customers to rival services.

Shares in Paytm have nearly tripled since June after India’s payments regulator allowed it to resume adding customers to its flagship UPI service. The company reported its first quarterly profit in September, though this was largely due to proceeds from asset sales rather than operational improvements.

“We are grateful to Masayoshi-san and the PayPay team for giving us the opportunity to together create a mobile payment revolution in Japan,” Paytm said in a statement. “We remain fully committed and will continue to support PayPay’s product and technology innovations in future. We are working on introducing new AI-powered features to accelerate PayPay’s vision in Japan.”

Saturday’s deal marks the end of Paytm’s relationship with SoftBank, which divested its remaining shares in June after being an early backer through its Vision Fund.



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

Accel could raise billions for India, but it’s sticking to $650 million

Accel has maintained its India fund size at $650 million for its eighth vehicle, even as other...

YouTuber LegalEagle sues PayPal over ‘sleeping leech’ Honey extension

A new lawsuit alleges that the PayPal-owned browser extension Honey is cheating creators out of money. Honey, which...

Roborock’s Roomba competitor gets a robot arm

iRobot’s on-going financial crisis aside, the world of robot vacuums is still humming along. At CES Sunday,...

Bad news for Adrian Dittman/Elon Musk truthers

After days of speculation that X owner Elon Musk was secretly posting under an account named Adrian...

United Airlines accelerates its Starlink rollout, with first commercial flight planned for spring

A few months ago, United Airlines announced its deal with Starlink to offer in-flight internet access for...

From forced landings to stuffed animal heads, headhunter Peterson Conway is defense tech’s wildest power broker

In 2023, defense tech recruiter Peterson Conway VIII pulled up to the offices of nuclear fusion startup...

Tenable CEO Amit Yoran dies

Longtime entrepreneur and cybersecurity executive Amit Yoran passed away Friday after a battle with cancer. Cybersecurity company Tenable,...

Lyft will credit NYC riders for congestion fee throughout January

New York City’s congestion pricing is scheduled to take effect Sunday — but for the first month,...